BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Burdo TH, Lentz MR, Autissier P, Krishnan A, Halpern E, Letendre S, Rosenberg ES, Ellis RJ, Williams KC. Soluble CD163 made by monocyte/macrophages is a novel marker of HIV activity in early and chronic infection prior to and after anti-retroviral therapy. J Infect Dis. 2011;204:154-163. [PMID: 21628670 DOI: 10.1093/infdis/jir214] [Cited by in Crossref: 220] [Cited by in F6Publishing: 224] [Article Influence: 20.0] [Reference Citation Analysis]
Number Citing Articles
1 Beltrán LM, Muñoz Hernández R, de Pablo Bernal RS, García Morillo JS, Egido J, Noval ML, Ferrando-Martinez S, Blanco-Colio LM, Genebat M, Villar JR, Moreno-Luna R, Moreno JA. Reduced sTWEAK and increased sCD163 levels in HIV-infected patients: modulation by antiretroviral treatment, HIV replication and HCV co-infection. PLoS One 2014;9:e90541. [PMID: 24594990 DOI: 10.1371/journal.pone.0090541] [Cited by in Crossref: 40] [Cited by in F6Publishing: 40] [Article Influence: 5.0] [Reference Citation Analysis]
2 Siedner MJ, Kim JH, Nakku RS, Bibangambah P, Hemphill L, Triant VA, Haberer JE, Martin JN, Mocello AR, Boum Y 2nd, Kwon DS, Tracy RP, Burdo T, Huang Y, Cao H, Okello S, Bangsberg DR, Hunt PW. Persistent Immune Activation and Carotid Atherosclerosis in HIV-Infected Ugandans Receiving Antiretroviral Therapy. J Infect Dis 2016;213:370-8. [PMID: 26347573 DOI: 10.1093/infdis/jiv450] [Cited by in Crossref: 48] [Cited by in F6Publishing: 51] [Article Influence: 6.9] [Reference Citation Analysis]
3 Miller M, Lee J, Fulcher JA, Roach ME, Dilworth SE, Chahine A, Pallikkuth S, Fuchs D, Pahwa S, Carrico AW. Getting to the point: Methamphetamine injection is associated with biomarkers relevant to HIV pathogenesis. Drug and Alcohol Dependence 2020;213:108133. [DOI: 10.1016/j.drugalcdep.2020.108133] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
4 Hartmann S, Jakobus C, Rengstl B, Döring C, Newrzela S, Brodt H, Wolf T, Hansmann M. Spindle-shaped CD163+ rosetting macrophages replace CD4+ T-cells in HIV-related classical Hodgkin lymphoma. Mod Pathol 2013;26:648-57. [DOI: 10.1038/modpathol.2012.217] [Cited by in Crossref: 28] [Cited by in F6Publishing: 22] [Article Influence: 3.1] [Reference Citation Analysis]
5 Lakritz JR, Robinson JA, Polydefkis MJ, Miller AD, Burdo TH. Loss of intraepidermal nerve fiber density during SIV peripheral neuropathy is mediated by monocyte activation and elevated monocyte chemotactic proteins. J Neuroinflammation 2015;12:237. [PMID: 26683323 DOI: 10.1186/s12974-015-0456-8] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
6 Heravi AS, Etzkorn LH, Urbanek JK, Crainiceanu CM, Punjabi NM, Ashikaga H, Brown TT, Budoff MJ, D'Souza G, Magnani JW, Palella FJ Jr, Berger RD, Wu KC, Post WS. HIV Infection Is Associated With Variability in Ventricular Repolarization: The Multicenter AIDS Cohort Study (MACS). Circulation 2020;141:176-87. [PMID: 31707799 DOI: 10.1161/CIRCULATIONAHA.119.043042] [Cited by in Crossref: 9] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
7 Dickens AM, Yoo SW, Chin AC, Xu J, Johnson TP, Trout AL, Hauser KF, Haughey NJ. Chronic low-level expression of HIV-1 Tat promotes a neurodegenerative phenotype with aging. Sci Rep 2017;7:7748. [PMID: 28798382 DOI: 10.1038/s41598-017-07570-5] [Cited by in Crossref: 36] [Cited by in F6Publishing: 38] [Article Influence: 7.2] [Reference Citation Analysis]
8 Nielsen MC, Andersen MN, Rittig N, Rødgaard-Hansen S, Grønbaek H, Moestrup SK, Møller HJ, Etzerodt A. The macrophage-related biomarkers sCD163 and sCD206 are released by different shedding mechanisms. J Leukoc Biol 2019;106:1129-38. [PMID: 31242338 DOI: 10.1002/JLB.3A1218-500R] [Cited by in Crossref: 13] [Cited by in F6Publishing: 6] [Article Influence: 4.3] [Reference Citation Analysis]
9 Tandon R, Chew GM, Byron MM, Borrow P, Niki T, Hirashima M, Barbour JD, Norris PJ, Lanteri MC, Martin JN, Deeks SG, Ndhlovu LC. Galectin-9 is rapidly released during acute HIV-1 infection and remains sustained at high levels despite viral suppression even in elite controllers. AIDS Res Hum Retroviruses 2014;30:654-64. [PMID: 24786365 DOI: 10.1089/AID.2014.0004] [Cited by in Crossref: 41] [Cited by in F6Publishing: 39] [Article Influence: 5.1] [Reference Citation Analysis]
10 Yoshio S, Kanto T. Macrophages as a source of fibrosis biomarkers for non-alcoholic fatty liver disease. Immunol Med 2021;44:175-86. [PMID: 33444517 DOI: 10.1080/25785826.2020.1868664] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
11 Kapetanovic S, Giganti MJ, Abzug MJ, Lindsey JC, Sirois PA, Montepiedra G, Canniff J, Agwu A, Boivin MJ, Weinberg A; International Maternal Pediatric Adolescent AIDS Clinical Trials (IMPAACT) network. Plasma biomarker factors associated with neurodevelopmental outcomes in children with perinatal HIV infection and controlled viremia. AIDS 2021;35:1375-84. [PMID: 33710019 DOI: 10.1097/QAD.0000000000002862] [Reference Citation Analysis]
12 Underwood ML, Nguyen T, Uebelhoer LS, Kunkel LE, Korthuis PT, Lancioni CL. Altered monocyte phenotype and dysregulated innate cytokine responses among people living with HIV and opioid-use disorder. AIDS 2020;34:177-88. [PMID: 31687981 DOI: 10.1097/QAD.0000000000002416] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
13 Nou E, Lo J, Grinspoon SK. Inflammation, immune activation, and cardiovascular disease in HIV. AIDS 2016;30:1495-509. [PMID: 27058351 DOI: 10.1097/QAD.0000000000001109] [Cited by in Crossref: 95] [Cited by in F6Publishing: 56] [Article Influence: 19.0] [Reference Citation Analysis]
14 Ye H, Wang LY, Zhao J, Wang K. Increased CD163 expression is associated with acute-on-chronic hepatitis B liver failure. World J Gastroenterol 2013; 19(18): 2818-2825 [PMID: 23687420 DOI: 10.3748/wjg.v19.i18.2818] [Cited by in CrossRef: 18] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
15 Stewart DA, Yang Y, Makowski L, Troester MA. Basal-like breast cancer cells induce phenotypic and genomic changes in macrophages. Mol Cancer Res 2012;10:727-38. [PMID: 22532586 DOI: 10.1158/1541-7786.MCR-11-0604] [Cited by in Crossref: 66] [Cited by in F6Publishing: 47] [Article Influence: 6.6] [Reference Citation Analysis]
16 Xiao W, He H, Tong Y, Cai M, Shi Y, Liu B, Wang J, Qin Y, Lai S. Transcriptome analysis of Trichophyton mentagrophytes–induced rabbit (Oryctolagus cuniculus) dermatophytosis. Microbial Pathogenesis 2018;114:350-6. [DOI: 10.1016/j.micpath.2017.12.018] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
17 Anzinger JJ, Butterfield TR, Angelovich TA, Crowe SM, Palmer CS. Monocytes as regulators of inflammation and HIV-related comorbidities during cART. J Immunol Res 2014;2014:569819. [PMID: 25025081 DOI: 10.1155/2014/569819] [Cited by in Crossref: 53] [Cited by in F6Publishing: 56] [Article Influence: 6.6] [Reference Citation Analysis]
18 Gill AJ, Kolson DL. Chronic inflammation and the role for cofactors (hepatitis C, drug abuse, antiretroviral drug toxicity, aging) in HAND persistence. Curr HIV/AIDS Rep 2014;11:325-35. [PMID: 24929842 DOI: 10.1007/s11904-014-0210-3] [Cited by in Crossref: 40] [Cited by in F6Publishing: 41] [Article Influence: 5.7] [Reference Citation Analysis]
19 Benki-Nugent SF, Martopullo I, Laboso T, Tamasha N, Wamalwa DC, Tapia K, Langat A, Maleche-Obimbo E, Marra CM, Bangirana P, Boivin MJ, John-Stewart GC. High Plasma Soluble CD163 During Infancy Is a Marker for Neurocognitive Outcomes in Early-Treated HIV-Infected Children. J Acquir Immune Defic Syndr 2019;81:102-9. [PMID: 30768490 DOI: 10.1097/QAI.0000000000001979] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
20 Fourman LT, Pan CS, Zheng I, Gerard ME, Sheehab A, Lee H, Stanley TL, Grinspoon SK. Association of In Utero HIV Exposure With Obesity and Reactive Airway Disease in HIV-Negative Adolescents and Young Adults. J Acquir Immune Defic Syndr 2020;83:126-34. [PMID: 31738195 DOI: 10.1097/QAI.0000000000002235] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
21 Ticona E, Bull ME, Soria J, Tapia K, Legard J, Styrchak SM, Williams C, Mitchell C, La Rosa A, Rosa AL, Coombs RW, Frenkel LM. Biomarkers of inflammation in HIV-infected Peruvian men and women before and during suppressive antiretroviral therapy. AIDS 2015;29:1617-22. [PMID: 26372272 DOI: 10.1097/QAD.0000000000000758] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
22 Devanathan AS, Kashuba ADM. Human Immunodeficiency Virus Persistence in the Spleen: Opportunities for Pharmacologic Intervention. AIDS Res Hum Retroviruses 2021. [PMID: 33499746 DOI: 10.1089/AID.2020.0266] [Reference Citation Analysis]
23 Liang H, Duan Z, Li D, Li D, Wang Z, Ren L, Shen T, Shao Y. Higher levels of circulating monocyte-platelet aggregates are correlated with viremia and increased sCD163 levels in HIV-1 infection. Cell Mol Immunol 2015;12:435-43. [PMID: 25109683 DOI: 10.1038/cmi.2014.66] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 3.0] [Reference Citation Analysis]
24 O'Malley TK, Burdo TH, Robinson JA, Fitch KV, Grinspoon SK, Srinivasa S. Acute hyperinsulinemia effects on systemic markers of immune activation in HIV. AIDS 2017;31:1771-3. [PMID: 28514281 DOI: 10.1097/QAD.0000000000001545] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
25 Clifford KM, Samboju V, Cobigo Y, Milanini B, Marx GA, Hellmuth JM, Rosen HJ, Kramer JH, Allen IE, Valcour VG. Progressive Brain Atrophy Despite Persistent Viral Suppression in HIV Patients Older Than 60 Years. J Acquir Immune Defic Syndr 2017;76:289-97. [PMID: 28650401 DOI: 10.1097/QAI.0000000000001489] [Cited by in Crossref: 40] [Cited by in F6Publishing: 22] [Article Influence: 8.0] [Reference Citation Analysis]
26 Metkus TS, Brown T, Budoff M, Kingsley L, Palella FJ Jr, Witt MD, Li X, George RT, Jacobson LP, Post WS. HIV infection is associated with an increased prevalence of coronary noncalcified plaque among participants with a coronary artery calcium score of zero: Multicenter AIDS Cohort Study (MACS). HIV Med 2015;16:635-9. [PMID: 25968104 DOI: 10.1111/hiv.12262] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 2.9] [Reference Citation Analysis]
27 Mallard J, Williams K. An SIV macaque model of SIV and HAND: the need for adjunctive therapies in HIV that target activated monocytes and macrophages. J Neurovirol 2018;24:213-9. [PMID: 29435829 DOI: 10.1007/s13365-018-0616-6] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
28 Dentone C, Di Biagio A, Parodi A, Bozzano F, Fraccaro P, Signori A, Cenderello G, Mantia E, Orofino G, De Maria A, Filaci G, Fenoglio D. Innate immunity cell activation in virologically suppressed HIV-infected maraviroc-treated patients. AIDS 2014;28:1071-4. [DOI: 10.1097/qad.0000000000000194] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
29 Burdo TH, Weiffenbach A, Woods SP, Letendre S, Ellis RJ, Williams KC. Elevated sCD163 in plasma but not cerebrospinal fluid is a marker of neurocognitive impairment in HIV infection. AIDS 2013;27:1387-95. [PMID: 23435298 DOI: 10.1097/QAD.0b013e32836010bd] [Cited by in Crossref: 170] [Cited by in F6Publishing: 137] [Article Influence: 18.9] [Reference Citation Analysis]
30 Hønge BL, Andersen MN, Jespersen S, Medina C, Correira FG, Jakobsen MR, Laursen A, Erikstrup C, Møller HJ, Wejse C; Bissau HIV cohort study group. Brief Report: Macrophage Activation in HIV-2-Infected Patients Is Less Affected by Antiretroviral Treatment-sCD163 in HIV-1, HIV-2, and HIV-1/2 Dually Infected Patients. J Acquir Immune Defic Syndr 2016;72:254-8. [PMID: 26825178 DOI: 10.1097/QAI.0000000000000939] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 1.6] [Reference Citation Analysis]
31 Bruzzesi E, Sereti I. Residual Immune Activation and Latency. Curr Top Microbiol Immunol 2018;417:157-80. [PMID: 30105422 DOI: 10.1007/82_2018_118] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
32 Leeansyah E, Malone DF, Anthony DD, Sandberg JK. Soluble biomarkers of HIV transmission, disease progression and comorbidities: . Current Opinion in HIV and AIDS 2013;8:117-24. [DOI: 10.1097/coh.0b013e32835c7134] [Cited by in Crossref: 49] [Cited by in F6Publishing: 33] [Article Influence: 5.4] [Reference Citation Analysis]
33 Mallard J, Williams KC. Animal models of HIV-associated disease of the central nervous system. Handb Clin Neurol 2018;152:41-53. [PMID: 29604983 DOI: 10.1016/B978-0-444-63849-6.00004-9] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
34 Skytthe MK, Graversen JH, Moestrup SK. Targeting of CD163+ Macrophages in Inflammatory and Malignant Diseases. Int J Mol Sci 2020;21:E5497. [PMID: 32752088 DOI: 10.3390/ijms21155497] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 7.5] [Reference Citation Analysis]
35 Zanni MV, Burdo TH, Makimura H, Williams KC, Grinspoon SK. Relationship between monocyte/macrophage activation marker soluble CD163 and insulin resistance in obese and normal-weight subjects. Clin Endocrinol (Oxf) 2012;77:385-90. [PMID: 22098563 DOI: 10.1111/j.1365-2265.2011.04284.x] [Cited by in Crossref: 50] [Cited by in F6Publishing: 51] [Article Influence: 5.6] [Reference Citation Analysis]
36 Zhang T, Sun J, Du H, Su H, Zhang Y, Jin Q. Metabolic characterization of plasma samples in HIV-1-infected individuals. Future Microbiol 2018;13:985-96. [PMID: 29932349 DOI: 10.2217/fmb-2017-0306] [Reference Citation Analysis]
37 Hunt PW. HIV and inflammation: mechanisms and consequences. Curr HIV/AIDS Rep. 2012;9:139-147. [PMID: 22528766 DOI: 10.1007/s11904-012-0118-8] [Cited by in Crossref: 249] [Cited by in F6Publishing: 247] [Article Influence: 24.9] [Reference Citation Analysis]
38 Weiner LD, Retuerto M, Hager CL, El Kamari V, Shan L, Sattar A, Kulkarni M, Funderburg N, Ghannoum MA, Dirajlal-Fargo S, McComsey GA. Fungal Translocation Is Associated with Immune Activation and Systemic Inflammation in Treated HIV. AIDS Res Hum Retroviruses 2019;35:461-72. [PMID: 30784316 DOI: 10.1089/AID.2018.0252] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
39 Guzmán-Fulgencio M, Jiménez JL, Jiménez-Sousa MA, Bellón JM, García-Álvarez M, Soriano V, Gijón-Vidaurreta P, Bernal-Morell E, Viciana P, Muñoz-Fernández MÁ, Resino S. ACSM4 polymorphisms are associated with rapid AIDS progression in HIV-infected patients. J Acquir Immune Defic Syndr 2014;65:27-32. [PMID: 23982661 DOI: 10.1097/QAI.0b013e3182a990e2] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
40 Knudsen A, Kristoffersen US, Kjær A, Lebech A. Cardiovascular disease in patients with HIV. Future Virology 2012;7:413-23. [DOI: 10.2217/fvl.12.25] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
41 Royal W 3rd, Cherner M, Burdo TH, Umlauf A, Letendre SL, Jumare J, Abimiku A, Alabi P, Alkali N, Bwala S, Okwuasaba K, Eyzaguirre LM, Akolo C, Guo M, Williams KC, Blattner WA. Associations between Cognition, Gender and Monocyte Activation among HIV Infected Individuals in Nigeria. PLoS One 2016;11:e0147182. [PMID: 26829391 DOI: 10.1371/journal.pone.0147182] [Cited by in Crossref: 52] [Cited by in F6Publishing: 56] [Article Influence: 8.7] [Reference Citation Analysis]
42 Kirkegaard-Klitbo DM, Mejer N, Knudsen TB, Møller HJ, Moestrup SK, Poulsen SD, Kronborg G, Benfield T. Soluble CD163 predicts incident chronic lung, kidney and liver disease in HIV infection. AIDS 2017;31:981-8. [PMID: 28252527 DOI: 10.1097/QAD.0000000000001432] [Cited by in Crossref: 20] [Cited by in F6Publishing: 13] [Article Influence: 5.0] [Reference Citation Analysis]
43 Kallianpur KJ, Jahanshad N, Sailasuta N, Benjapornpong K, Chan P, Pothisri M, Dumrongpisutikul N, Laws E, Ndhlovu LC, Clifford KM, Paul R, Jagodzinski L, Krebs S, Ananworanich J, Spudich S, Valcour V; SEARCH010/RV254 Study Group. Regional brain volumetric changes despite 2 years of treatment initiated during acute HIV infection. AIDS 2020;34:415-26. [PMID: 31725432 DOI: 10.1097/QAD.0000000000002436] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 7.0] [Reference Citation Analysis]
44 Wang RJ, Moore J, Moisi D, Chang EG, Byanyima P, Kaswabuli S, Musisi E, Sanyu I, Sessolo A, Lalitha R, Worodria W, Davis JL, Crothers K, Lin J, Lederman MM, Hunt PW, Huang L. HIV infection is associated with elevated biomarkers of immune activation in Ugandan adults with pneumonia. PLoS One 2019;14:e0216680. [PMID: 31091258 DOI: 10.1371/journal.pone.0216680] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
45 Hearps AC, Martin GE, Rajasuriar R, Crowe SM. Inflammatory co-morbidities in HIV+ individuals: learning lessons from healthy ageing. Curr HIV/AIDS Rep 2014;11:20-34. [PMID: 24414166 DOI: 10.1007/s11904-013-0190-8] [Cited by in Crossref: 57] [Cited by in F6Publishing: 51] [Article Influence: 7.1] [Reference Citation Analysis]
46 Hunt PW. HIV and aging: emerging research issues. Curr Opin HIV AIDS 2014;9:302-8. [PMID: 24824891 DOI: 10.1097/COH.0000000000000072] [Cited by in Crossref: 33] [Cited by in F6Publishing: 22] [Article Influence: 4.7] [Reference Citation Analysis]
47 Toribio M, Park MH, Zanni MV, Robbins GK, Burdo TH, Williams KC, Feldpausch MN, Stone L, Melbourne K, Grinspoon SK, Fitzgerald ML. HDL Cholesterol Efflux Capacity in Newly Diagnosed HIV and Effects of Antiretroviral Therapy. J Clin Endocrinol Metab 2017;102:4250-9. [PMID: 28945911 DOI: 10.1210/jc.2017-01334] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
48 Smail RC, Brew BJ. HIV-associated neurocognitive disorder. Handb Clin Neurol 2018;152:75-97. [PMID: 29604986 DOI: 10.1016/B978-0-444-63849-6.00007-4] [Cited by in Crossref: 26] [Cited by in F6Publishing: 17] [Article Influence: 6.5] [Reference Citation Analysis]
49 Spagnolo-Allende A, Gutierrez J. Role of Brain Arterial Remodeling in HIV-Associated Cerebrovascular Outcomes. Front Neurol 2021;12:593605. [PMID: 34239489 DOI: 10.3389/fneur.2021.593605] [Reference Citation Analysis]
50 Swartz TH, Dubyak GR, Chen BK. Purinergic Receptors: Key Mediators of HIV-1 Infection and Inflammation. Front Immunol 2015;6:585. [PMID: 26635799 DOI: 10.3389/fimmu.2015.00585] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
51 Maggiolo F, Bandera A, Bonora S, Borderi M, Calcagno A, Cattelan A, Cingolani A, Gianotti N, Lichtner M, Lo Caputo S, Madeddu G, Maggi P, Marchetti GC, Maserati R, Nozza S, Rusconi S, Zazzi M, Di Biagio A. Enhancing care for people living with HIV: current and future monitoring approaches. Expert Rev Anti Infect Ther 2021;19:443-56. [PMID: 33054479 DOI: 10.1080/14787210.2021.1823217] [Reference Citation Analysis]
52 Rackova L, Mach M, Brnoliakova Z. An update in toxicology of ageing. Environ Toxicol Pharmacol 2021;84:103611. [PMID: 33581363 DOI: 10.1016/j.etap.2021.103611] [Reference Citation Analysis]
53 Thudium RF, Knudsen AD, Von Stemann JH, Hove-Skovsgaard M, Hoel H, Mocroft A, Reekie J, Ronit A, Gerstoft J, Vestbo J, Trøseid M, Borges ÁH, Ostrowski SR, Nielsen SD. Independent Association of Interleukin 6 With Low Dynamic Lung Function and Airflow Limitation in Well-Treated People With Human Immunodeficiency Virus. J Infect Dis 2021;223:1690-8. [PMID: 33141877 DOI: 10.1093/infdis/jiaa600] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
54 O'Halloran JA, Dunne E, Gurwith M, Lambert JS, Sheehan GJ, Feeney ER, Pozniak A, Reiss P, Kenny D, Mallon P. The effect of initiation of antiretroviral therapy on monocyte, endothelial and platelet function in HIV-1 infection. HIV Med 2015;16:608-19. [PMID: 26111187 DOI: 10.1111/hiv.12270] [Cited by in Crossref: 38] [Cited by in F6Publishing: 41] [Article Influence: 5.4] [Reference Citation Analysis]
55 Chow FC, Boscardin WJ, Mills C, Ko N, Carroll C, Price RW, Deeks S, Sorond FA, Hsue PY. Cerebral vasoreactivity is impaired in treated, virally suppressed HIV-infected individuals. AIDS 2016;30:45-55. [PMID: 26372478 DOI: 10.1097/QAD.0000000000000875] [Cited by in Crossref: 10] [Cited by in F6Publishing: 14] [Article Influence: 1.7] [Reference Citation Analysis]
56 Ravimohan S, Tamuhla N, Steenhoff AP, Letlhogile R, Makutu DK, Nfanyana K, Rantleru T, Tierney A, Nkakana K, Schwartz AB, Gross R, Macgregor RR, Bellamy SL, Frank I, Weissman D, Bisson GP. Early immunologic failure is associated with early mortality among advanced HIV-infected adults initiating antiretroviral therapy with active tuberculosis. J Infect Dis 2013;208:1784-93. [PMID: 23908475 DOI: 10.1093/infdis/jit368] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 2.3] [Reference Citation Analysis]
57 McClendon CJ, Gerald CL, Waterman JT. Farm animal models of organic dust exposure and toxicity: insights and implications for respiratory health. Curr Opin Allergy Clin Immunol 2015;15:137-44. [PMID: 25636160 DOI: 10.1097/ACI.0000000000000143] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
58 Kearns AC, Robinson JA, Shekarabi M, Liu F, Qin X, Burdo TH. Caspase-1-associated immune activation in an accelerated SIV-infected rhesus macaque model. J Neurovirol 2018;24:420-31. [PMID: 29611111 DOI: 10.1007/s13365-018-0630-8] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
59 Iannetta M, Isnard S, Manuzak J, Guillerme JB, Notin M, Bailly K, Andrieu M, Amraoui S, Vimeux L, Figueiredo S, Charmeteau-de Muylder B, Vaton L, Hatton EX, Samri A, Autran B, Thiébaut R, Chaghil N, Glohi D, Charpentier C, Descamps D, Brun-Vézinet F, Matheron S, Cheynier R, Hosmalin A. Conventional Dendritic Cells and Slan+ Monocytes During HIV-2 Infection. Front Immunol 2020;11:1658. [PMID: 32903610 DOI: 10.3389/fimmu.2020.01658] [Reference Citation Analysis]
60 Korolevskaya LB, Shmagel KV, Shmagel NG, Saidakova EV. Systemic activation of the immune system in HIV infection: The role of the immune complexes (hypothesis). Med Hypotheses 2016;88:53-6. [PMID: 26880638 DOI: 10.1016/j.mehy.2016.01.009] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
61 Castley A, Williams L, James I, Guelfi G, Berry C, Nolan D. Plasma CXCL10, sCD163 and sCD14 Levels Have Distinct Associations with Antiretroviral Treatment and Cardiovascular Disease Risk Factors. PLoS One 2016;11:e0158169. [PMID: 27355513 DOI: 10.1371/journal.pone.0158169] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 2.8] [Reference Citation Analysis]
62 Letendre S, Bharti A, Perez-Valero I, Hanson B, Franklin D, Woods SP, Gianella S, de Oliveira MF, Heaton RK, Grant I, Landay AL, Lurain N; CNS HIV AntiRetroviral Therapy Effects Research (CHARTER) Group. Higher Anti-Cytomegalovirus Immunoglobulin G Concentrations Are Associated With Worse Neurocognitive Performance During Suppressive Antiretroviral Therapy. Clin Infect Dis 2018;67:770-7. [PMID: 29506084 DOI: 10.1093/cid/ciy170] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
63 Guo K, Shen G, Kibbie J, Gonzalez T, Dillon SM, Smith HA, Cooper EH, Lavender K, Hasenkrug KJ, Sutter K, Dittmer U, Kroehl M, Kechris K, Wilson CC, Santiago ML. Qualitative Differences Between the IFNα subtypes and IFNβ Influence Chronic Mucosal HIV-1 Pathogenesis. PLoS Pathog 2020;16:e1008986. [PMID: 33064743 DOI: 10.1371/journal.ppat.1008986] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
64 Elvstam O, Medstrand P, Jansson M, Isberg PE, Gisslén M, Björkman P. Is low-level HIV-1 viraemia associated with elevated levels of markers of immune activation, coagulation and cardiovascular disease? HIV Med 2019;20:571-80. [PMID: 31148335 DOI: 10.1111/hiv.12756] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
65 Zingaropoli MA, Nijhawan P, Carraro A, Pasculli P, Zuccalà P, Perri V, Marocco R, Kertusha B, Siccardi G, Del Borgo C, Curtolo A, Ajassa C, Iannetta M, Ciardi MR, Mastroianni CM, Lichtner M. Increased sCD163 and sCD14 Plasmatic Levels and Depletion of Peripheral Blood Pro-Inflammatory Monocytes, Myeloid and Plasmacytoid Dendritic Cells in Patients With Severe COVID-19 Pneumonia. Front Immunol 2021;12:627548. [PMID: 33777012 DOI: 10.3389/fimmu.2021.627548] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 10.0] [Reference Citation Analysis]
66 Titanji B, Gavegnano C, Hsue P, Schinazi R, Marconi VC. Targeting Inflammation to Reduce Atherosclerotic Cardiovascular Risk in People With HIV Infection. J Am Heart Assoc 2020;9:e014873. [PMID: 31973607 DOI: 10.1161/JAHA.119.014873] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 5.5] [Reference Citation Analysis]
67 Galvão-Lima LJ, Espíndola MS, Soares LS, Zambuzi FA, Cacemiro M, Fontanari C, Bollela VR, Frantz FG. Classical and alternative macrophages have impaired function during acute and chronic HIV-1 infection. Braz J Infect Dis 2017;21:42-50. [PMID: 27912071 DOI: 10.1016/j.bjid.2016.10.004] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
68 Ananworanich J, Kerr SJ, Jaimulwong T, Vibol U, Hansudewechakul R, Kosalaraksa P, Ngampiyaskul C, Kanjanavanit S, Wongsawat J, Luesomboon W, Apornpong T, Soulas C, Paul R, Ruxrungtham K, Puthanakit T. Soluble CD163 and monocyte populations in response to antiretroviral therapy and in relationship with neuropsychological testing among HIV-infected children. Journal of Virus Eradication 2015;1:196-202. [DOI: 10.1016/s2055-6640(20)30501-x] [Cited by in Crossref: 14] [Article Influence: 2.0] [Reference Citation Analysis]
69 Castley A, Berry C, French M, Fernandez S, Krueger R, Nolan D. Elevated plasma soluble CD14 and skewed CD16+ monocyte distribution persist despite normalisation of soluble CD163 and CXCL10 by effective HIV therapy: a changing paradigm for routine HIV laboratory monitoring? PLoS One 2014;9:e115226. [PMID: 25544986 DOI: 10.1371/journal.pone.0115226] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 2.6] [Reference Citation Analysis]
70 Campillo-Gimenez L, Assoumou L, Valantin MA, Pajanirassa P, Villemonteix J, Soulié C, Marcelin AG, Costagliola D, Capeau J, Autran B, Katlama C, Guihot A; ROCnRAL ANRS 157 Study Group. Switch to maraviroc/raltegravir dual therapy leads to an unfavorable immune profile with low-level HIV viremia. AIDS 2015;29:853-6. [PMID: 25719828 DOI: 10.1097/QAD.0000000000000626] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
71 Cinkajzlová A, Lacinová Z, Kloučková J, Kaválková P, Trachta P, Kosák M, Krátký J, Kasalický M, Doležalová K, Mráz M, Haluzík M. An Alternatively Activated Macrophage Marker CD163 in Severely Obese Patients: the Influence of Very Low-Calorie Diet and Bariatric Surgery. Physiol Res. [DOI: 10.33549/physiolres.933522] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
72 Zani IA, Stephen SL, Mughal NA, Russell D, Homer-Vanniasinkam S, Wheatcroft SB, Ponnambalam S. Scavenger receptor structure and function in health and disease. Cells. 2015;4:178-201. [PMID: 26010753 DOI: 10.3390/cells4020178] [Cited by in Crossref: 163] [Cited by in F6Publishing: 147] [Article Influence: 23.3] [Reference Citation Analysis]
73 Luscombe CA, Avihingsanon A, Supparatpinyo K, Gatechompol S, Han WM, Ewart GD, Thomson AS, Miller M, Becker S, Murphy RL. Human Immunodeficiency Virus Type 1 Vpu Inhibitor, BIT225, in Combination with 3-Drug Antiretroviral Therapy: Inflammation and Immune Cell Modulation. J Infect Dis 2021;223:1914-22. [PMID: 33038249 DOI: 10.1093/infdis/jiaa635] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
74 Booiman T, Wit FW, Maurer I, De Francesco D, Sabin CA, Harskamp AM, Prins M, Garagnani P, Pirazzini C, Franceschi C, Fuchs D, Gisslén M, Winston A, Reiss P, Kootstra NA; Comorbidity in Relation to AIDS (COBRA) Collaboration . High Cellular Monocyte Activation in People Living With Human Immunodeficiency Virus on Combination Antiretroviral Therapy and Lifestyle-Matched Controls Is Associated With Greater Inflammation in Cerebrospinal Fluid. Open Forum Infect Dis 2017;4:ofx108. [PMID: 28680905 DOI: 10.1093/ofid/ofx108] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
75 Generoso M, Álvarez P, Kravietz A, Mwamzuka M, Marshed F, Ahmed A, Khaitan A. High soluble CD163 levels correlate with disease progression and inflammation in Kenyan children with perinatal HIV-infection. AIDS 2020;34:33-8. [PMID: 31567161 DOI: 10.1097/QAD.0000000000002378] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
76 Chang K, Premeaux TA, Cobigo Y, Milanini B, Hellmuth J, Rubin LH, Javandel S, Allen I, Ndhlovu LC, Paul R, Valcour V. Plasma inflammatory biomarkers link to diffusion tensor imaging metrics in virally suppressed HIV-infected individuals. AIDS 2020;34:203-13. [PMID: 31634200 DOI: 10.1097/QAD.0000000000002404] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
77 Krishnan S, Wilson EM, Sheikh V, Rupert A, Mendoza D, Yang J, Lempicki R, Migueles SA, Sereti I. Evidence for innate immune system activation in HIV type 1-infected elite controllers. J Infect Dis 2014;209:931-9. [PMID: 24185941 DOI: 10.1093/infdis/jit581] [Cited by in Crossref: 93] [Cited by in F6Publishing: 94] [Article Influence: 10.3] [Reference Citation Analysis]
78 Imp BM, Rubin LH, Tien PC, Plankey MW, Golub ET, French AL, Valcour VG. Monocyte Activation Is Associated With Worse Cognitive Performance in HIV-Infected Women With Virologic Suppression. J Infect Dis 2017;215:114-21. [PMID: 27789726 DOI: 10.1093/infdis/jiw506] [Cited by in Crossref: 55] [Cited by in F6Publishing: 57] [Article Influence: 9.2] [Reference Citation Analysis]
79 Souriant S, Balboa L, Dupont M, Pingris K, Kviatcovsky D, Cougoule C, Lastrucci C, Bah A, Gasser R, Poincloux R, Raynaud-Messina B, Al Saati T, Inwentarz S, Poggi S, Moraña EJ, González-Montaner P, Corti M, Lagane B, Vergne I, Allers C, Kaushal D, Kuroda MJ, Sasiain MDC, Neyrolles O, Maridonneau-Parini I, Lugo-Villarino G, Vérollet C. Tuberculosis Exacerbates HIV-1 Infection through IL-10/STAT3-Dependent Tunneling Nanotube Formation in Macrophages. Cell Rep 2019;26:3586-3599.e7. [PMID: 30917314 DOI: 10.1016/j.celrep.2019.02.091] [Cited by in Crossref: 38] [Cited by in F6Publishing: 36] [Article Influence: 19.0] [Reference Citation Analysis]
80 Henrich TJ, Gandhi RT. Early treatment and HIV-1 reservoirs: a stitch in time? J Infect Dis 2013;208:1189-93. [PMID: 23852126 DOI: 10.1093/infdis/jit307] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
81 Grinspoon SK, Fitch KV, Overton ET, Fichtenbaum CJ, Zanni MV, Aberg JA, Malvestutto C, Lu MT, Currier JS, Sponseller CA, Waclawiw M, Alston-Smith B, Cooper-Arnold K, Klingman KL, Desvigne-Nickens P, Hoffmann U, Ribaudo HJ, Douglas PS; REPRIEVE Investigators. Rationale and design of the Randomized Trial to Prevent Vascular Events in HIV (REPRIEVE). Am Heart J 2019;212:23-35. [PMID: 30928825 DOI: 10.1016/j.ahj.2018.12.016] [Cited by in Crossref: 49] [Cited by in F6Publishing: 51] [Article Influence: 16.3] [Reference Citation Analysis]
82 Rajasuriar R, Kong YY, Nadarajah R, Abdullah NK, Spelman T, Yuhana MY, Ponampalavanar S, Kamarulzaman A, Lewin SR. The CD14 C-260T single nucleotide polymorphism (SNP) modulates monocyte/macrophage activation in treated HIV-infected individuals. J Transl Med 2015;13:30. [PMID: 25622527 DOI: 10.1186/s12967-015-0391-6] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
83 Jaworowski A, Hearps AC, Angelovich TA, Hoy JF. How Monocytes Contribute to Increased Risk of Atherosclerosis in Virologically-Suppressed HIV-Positive Individuals Receiving Combination Antiretroviral Therapy. Front Immunol 2019;10:1378. [PMID: 31275317 DOI: 10.3389/fimmu.2019.01378] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
84 Chu R, van Eeden C, Suresh S, Sligl WI, Osman M, Cohen Tervaert JW. Do COVID-19 Infections Result in a Different Form of Secondary Hemophagocytic Lymphohistiocytosis. Int J Mol Sci 2021;22:2967. [PMID: 33803997 DOI: 10.3390/ijms22062967] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
85 McCausland MR, Juchnowski SM, Zidar DA, Kuritzkes DR, Andrade A, Sieg SF, Lederman MM, Funderburg NT. Altered Monocyte Phenotype in HIV-1 Infection Tends to Normalize with Integrase-Inhibitor-Based Antiretroviral Therapy. PLoS One 2015;10:e0139474. [PMID: 26430882 DOI: 10.1371/journal.pone.0139474] [Cited by in Crossref: 15] [Cited by in F6Publishing: 19] [Article Influence: 2.1] [Reference Citation Analysis]
86 Dagenais-Lussier X, Mouna A, Routy JP, Tremblay C, Sekaly RP, El-Far M, Grevenynghe Jv. Current topics in HIV-1 pathogenesis: The emergence of deregulated immuno-metabolism in HIV-infected subjects. Cytokine Growth Factor Rev 2015;26:603-13. [PMID: 26409789 DOI: 10.1016/j.cytogfr.2015.09.001] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 4.3] [Reference Citation Analysis]
87 Walker NF, Meintjes G, Wilkinson RJ. HIV-1 and the immune response to TB. Future Virol 2013;8:57-80. [PMID: 23653664 DOI: 10.2217/fvl.12.123] [Cited by in Crossref: 41] [Cited by in F6Publishing: 39] [Article Influence: 4.6] [Reference Citation Analysis]
88 Wei X, Zhao T, Ai K, Li H, Jiang X, Li C, Wang Q, Yang J, Zhang R, Yang J. Role of scavenger receptor from Octopus ocellatus as a co-receptor of Toll-like receptor in initiation of TLR-NF-κB signaling during anti-bacterial response. Developmental & Comparative Immunology 2018;84:14-27. [DOI: 10.1016/j.dci.2018.01.023] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
89 Klatt NR, Chomont N, Douek DC, Deeks SG. Immune activation and HIV persistence: implications for curative approaches to HIV infection. Immunol Rev 2013;254:326-42. [PMID: 23772629 DOI: 10.1111/imr.12065] [Cited by in Crossref: 235] [Cited by in F6Publishing: 218] [Article Influence: 29.4] [Reference Citation Analysis]
90 Montoya JL, Iudicello J, Oppenheim HA, Fazeli PL, Potter M, Ma Q, Mills PJ, Ellis RJ, Grant I, Letendre SL, Moore DJ; HIV Neurobehavioral Research Program (HNRP) Group. Coagulation imbalance and neurocognitive functioning in older HIV-positive adults on suppressive antiretroviral therapy. AIDS 2017;31:787-95. [PMID: 28099190 DOI: 10.1097/QAD.0000000000001404] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
91 Espíndola MS, Lima LJ, Soares LS, Cacemiro MC, Zambuzi FA, de Souza Gomes M, Amaral LR, Bollela VR, Martins-Filho OA, Frantz FG. Dysregulated Immune Activation in Second-Line HAART HIV+ Patients Is Similar to That of Untreated Patients. PLoS One 2015;10:e0145261. [PMID: 26684789 DOI: 10.1371/journal.pone.0145261] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
92 Tawakol A, Ishai A, Li D, Takx RA, Hur S, Kaiser Y, Pampaloni M, Rupert A, Hsu D, Sereti I, Fromentin R, Chomont N, Ganz P, Deeks SG, Hsue PY. Association of Arterial and Lymph Node Inflammation With Distinct Inflammatory Pathways in Human Immunodeficiency Virus Infection. JAMA Cardiol 2017;2:163-71. [PMID: 27926762 DOI: 10.1001/jamacardio.2016.4728] [Cited by in Crossref: 36] [Cited by in F6Publishing: 30] [Article Influence: 12.0] [Reference Citation Analysis]
93 Deeks SG, Tracy R, Douek DC. Systemic effects of inflammation on health during chronic HIV infection. Immunity 2013;39:633-45. [PMID: 24138880 DOI: 10.1016/j.immuni.2013.10.001] [Cited by in Crossref: 408] [Cited by in F6Publishing: 388] [Article Influence: 45.3] [Reference Citation Analysis]
94 Sandler NG, Sereti I. Can early therapy reduce inflammation? Curr Opin HIV AIDS 2014;9:72-9. [PMID: 24247669 DOI: 10.1097/COH.0000000000000020] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 2.8] [Reference Citation Analysis]
95 De Francesco D, Wit FW, Bürkle A, Oehlke S, Kootstra NA, Winston A, Franceschi C, Garagnani P, Pirazzini C, Libert C, Grune T, Weber D, Jansen EHJM, Sabin CA, Reiss P; the Co-morBidity in Relation to AIDS (COBRA) Collaboration. Do people living with HIV experience greater age advancement than their HIV-negative counterparts? AIDS 2019;33:259-68. [PMID: 30325781 DOI: 10.1097/QAD.0000000000002063] [Cited by in Crossref: 42] [Cited by in F6Publishing: 22] [Article Influence: 21.0] [Reference Citation Analysis]
96 McGuire JL, Gill AJ, Douglas SD, Kolson DL; CNS HIV Anti-Retroviral Therapy Effects Research (CHARTER) group. Central and peripheral markers of neurodegeneration and monocyte activation in HIV-associated neurocognitive disorders. J Neurovirol 2015;21:439-48. [PMID: 25776526 DOI: 10.1007/s13365-015-0333-3] [Cited by in Crossref: 45] [Cited by in F6Publishing: 54] [Article Influence: 6.4] [Reference Citation Analysis]
97 Tabb B, Morcock DR, Trubey CM, Quiñones OA, Hao XP, Smedley J, Macallister R, Piatak M Jr, Harris LD, Paiardini M, Silvestri G, Brenchley JM, Alvord WG, Lifson JD, Estes JD. Reduced inflammation and lymphoid tissue immunopathology in rhesus macaques receiving anti-tumor necrosis factor treatment during primary simian immunodeficiency virus infection. J Infect Dis 2013;207:880-92. [PMID: 23087435 DOI: 10.1093/infdis/jis643] [Cited by in Crossref: 43] [Cited by in F6Publishing: 43] [Article Influence: 4.3] [Reference Citation Analysis]
98 Lugo-Villarino G, Vérollet C, Maridonneau-Parini I, Neyrolles O. Macrophage polarization: convergence point targeted by mycobacterium tuberculosis and HIV. Front Immunol 2011;2:43. [PMID: 22566833 DOI: 10.3389/fimmu.2011.00043] [Cited by in Crossref: 61] [Cited by in F6Publishing: 60] [Article Influence: 5.5] [Reference Citation Analysis]
99 Ahsan MH, Gill AF, Alvarez X, Lackner AA, Veazey RS. Kinetics of liver macrophages (Kupffer cells) in SIV-infected macaques. Virology 2013;446:77-85. [PMID: 24074569 DOI: 10.1016/j.virol.2013.07.026] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
100 Chen P, Su B, Zhang T, Zhu X, Xia W, Fu Y, Zhao G, Xia H, Dai L, Sun L, Liu L, Wu H. Perturbations of Monocyte Subsets and Their Association with T Helper Cell Differentiation in Acute and Chronic HIV-1-Infected Patients. Front Immunol 2017;8:272. [PMID: 28348563 DOI: 10.3389/fimmu.2017.00272] [Cited by in Crossref: 21] [Cited by in F6Publishing: 27] [Article Influence: 4.2] [Reference Citation Analysis]
101 Lidofsky A, Holmes JA, Feeney ER, Kruger AJ, Salloum S, Zheng H, Seguin IS, Altinbas A, Masia R, Corey KE, Gustafson JL, Schaefer EA, Hunt PW, Deeks S, Somsouk M, Chew KW, Chung RT, Alatrakchi N. Macrophage Activation Marker Soluble CD163 Is a Dynamic Marker of Liver Fibrogenesis in Human Immunodeficiency Virus/Hepatitis C Virus Coinfection. J Infect Dis 2018;218:1394-403. [PMID: 29868909 DOI: 10.1093/infdis/jiy331] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 6.7] [Reference Citation Analysis]
102 Campillo-gimenez L, Casulli S, Dudoit Y, Seang S, Carcelain G, Lambert-niclot S, Appay V, Autran B, Tubiana R, Elbim C. Neutrophils in antiretroviral therapy–controlled HIV demonstrate hyperactivation associated with a specific IL-17/IL-22 environment. Journal of Allergy and Clinical Immunology 2014;134:1142-1152.e5. [DOI: 10.1016/j.jaci.2014.05.040] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 3.4] [Reference Citation Analysis]
103 Nickoloff-Bybel EA, Festa L, Meucci O, Gaskill PJ. Co-receptor signaling in the pathogenesis of neuroHIV. Retrovirology 2021;18:24. [PMID: 34429135 DOI: 10.1186/s12977-021-00569-x] [Reference Citation Analysis]
104 Kim-Chang JJ, Donovan K, Loop MS, Hong S, Fischer B, Venturi G, Garvie PA, Kohn J, Rendina HJ, Woods SP, Goodenow MM, Nichols SL, Sleasman JW; Adolescent Medicine Trials Network for HIV/AIDS Interventions. Higher soluble CD14 levels are associated with lower visuospatial memory performance in youth with HIV. AIDS 2019;33:2363-74. [PMID: 31764101 DOI: 10.1097/QAD.0000000000002371] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
105 Patro SC, Pal S, Bi Y, Lynn K, Mounzer KC, Kostman JR, Davuluri RV, Montaner LJ. Shift in monocyte apoptosis with increasing viral load and change in apoptosis-related ISG/Bcl2 family gene expression in chronically HIV-1-infected subjects. J Virol 2015;89:799-810. [PMID: 25355877 DOI: 10.1128/JVI.02382-14] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
106 Vita S, Lichtner M, Marchetti G, Mascia C, Merlini E, Cicconi P, Vullo V, Viale P, Costantini A, DʼArminio Monforte A; for ICONA Foundation Study Group. Brief Report: Soluble CD163 in CMV-Infected and CMV-Uninfected Subjects on Virologically Suppressive Antiretroviral Therapy in the ICONA Cohort. J Acquir Immune Defic Syndr 2017;74:347-52. [PMID: 27828874 DOI: 10.1097/QAI.0000000000001232] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
107 Toossi Z, Funderburg NT, Sirdeshmuk S, Whalen CC, Nanteza MW, Johnson DF, Mayanja-Kizza H, Hirsch CS. Systemic immune activation and microbial translocation in dual HIV/tuberculosis-infected subjects. J Infect Dis 2013;207:1841-9. [PMID: 23479321 DOI: 10.1093/infdis/jit092] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.7] [Reference Citation Analysis]
108 Bull ME, Mitchell C, Soria J, Styrchak S, Williams-Wietzikoski C, Legard J, McKernan-Mullin J, Kraft K, Onchiri F, Stern J, Holte S, Ryan KJ, Acosta EP, La Rosa A, Coombs RW, Ticona E, Frenkel LM. Monotypic low-level HIV viremias during antiretroviral therapy are associated with disproportionate production of X4 virions and systemic immune activation. AIDS 2018;32:1389-401. [PMID: 29683841 DOI: 10.1097/QAD.0000000000001824] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
109 Paiardini M, Müller-Trutwin M. HIV-associated chronic immune activation. Immunol Rev 2013;254:78-101. [PMID: 23772616 DOI: 10.1111/imr.12079] [Cited by in Crossref: 221] [Cited by in F6Publishing: 209] [Article Influence: 27.6] [Reference Citation Analysis]
110 Kamkwalala AR, Wang X, Maki PM, Williams DW, Valcour VG, Damron A, Tien PC, Weber KM, Cohen MH, Sundermann EE, Meyer VJ, Little DM, Xu Y, Rubin LH. Brief Report: Higher Peripheral Monocyte Activation Markers Are Associated With Smaller Frontal and Temporal Cortical Volumes in Women With HIV. J Acquir Immune Defic Syndr 2020;84:54-9. [PMID: 31914004 DOI: 10.1097/QAI.0000000000002283] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
111 Younas M, Psomas C, Reynes J, Corbeau P. Immune activation in the course of HIV-1 infection: Causes, phenotypes and persistence under therapy. HIV Med. 2016;17:89-105. [PMID: 26452565 DOI: 10.1111/hiv.12310] [Cited by in Crossref: 82] [Cited by in F6Publishing: 86] [Article Influence: 11.7] [Reference Citation Analysis]
112 Sued O, Figueroa MI, Cahn P. Clinical challenges in HIV/AIDS: Hints for advancing prevention and patient management strategies. Adv Drug Deliv Rev 2016;103:5-19. [PMID: 27117711 DOI: 10.1016/j.addr.2016.04.016] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
113 Hearps A, Schafer K, High K, Landay A. HIV and Aging: Parallels and Synergistic Mechanisms Leading to Premature Disease and Functional Decline. In: Sierra F, Kohanski R, editors. Advances in Geroscience. Cham: Springer International Publishing; 2016. pp. 509-50. [DOI: 10.1007/978-3-319-23246-1_17] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
114 Muñoz-Nevárez LA, Imp BM, Eller MA, Kiweewa F, Maswai J, Polyak C, Olwenyi OA, Allen IE, Rono E, Milanini B, Kibuuka H, Ake JA, Eller LA, Valcour VG. Monocyte activation, HIV, and cognitive performance in East Africa. J Neurovirol 2020;26:52-9. [PMID: 31468471 DOI: 10.1007/s13365-019-00794-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
115 Kafka JK, Osborne BJ, Sheth PM, Nazli A, Dizzell S, Huibner S, Kovacs C, Verschoor CP, Bowdish DM, Kaul R, Kaushic C. Latent TGF-β1 is compartmentalized between blood and seminal plasma of HIV-positive men and its activation in semen is negatively correlated with viral load and immune activation. Am J Reprod Immunol 2015;73:151-61. [PMID: 25052241 DOI: 10.1111/aji.12300] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
116 Williams K, Lackner A, Mallard J. Non-human primate models of SIV infection and CNS neuropathology. Curr Opin Virol 2016;19:92-8. [PMID: 27544476 DOI: 10.1016/j.coviro.2016.07.012] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 3.2] [Reference Citation Analysis]
117 Selik RM, Linley L. Viral Loads Within 6 Weeks After Diagnosis of HIV Infection in Early and Later Stages: Observational Study Using National Surveillance Data. JMIR Public Health Surveill 2018;4:e10770. [PMID: 30401660 DOI: 10.2196/10770] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
118 Hearps AC, Agius PA, Zhou J, Brunt S, Chachage M, Angelovich TA, Cameron PU, Giles M, Price P, Elliott J, Jaworowski A. Persistence of Activated and Adaptive-Like NK Cells in HIV+ Individuals despite 2 Years of Suppressive Combination Antiretroviral Therapy. Front Immunol 2017;8:731. [PMID: 28713370 DOI: 10.3389/fimmu.2017.00731] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
119 Williams K, Burdo TH. Monocyte mobilization, activation markers, and unique macrophage populations in the brain: observations from SIV infected monkeys are informative with regard to pathogenic mechanisms of HIV infection in humans. J Neuroimmune Pharmacol 2012;7:363-71. [PMID: 22167311 DOI: 10.1007/s11481-011-9330-3] [Cited by in Crossref: 44] [Cited by in F6Publishing: 41] [Article Influence: 4.0] [Reference Citation Analysis]
120 He T, Falwell E, Brocca-Cofano E, Pandrea I. Modeling aging in HIV infection in nonhuman primates to address an emerging challenge of the post-ART era. Curr Opin Virol 2017;25:66-75. [PMID: 28803049 DOI: 10.1016/j.coviro.2017.07.012] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
121 Murray SM, Zhang Y, Douek DC, Sekaly RP. Myeloid Cells Enriched for a Dendritic Cell Population From People Living With HIV Have Altered Gene Expression Not Restored by Antiretroviral Therapy. Front Immunol 2020;11:261. [PMID: 32194550 DOI: 10.3389/fimmu.2020.00261] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
122 Ambegaokar SS, Kolson DL. Heme oxygenase-1 dysregulation in the brain: implications for HIV-associated neurocognitive disorders. Curr HIV Res 2014;12:174-88. [PMID: 24862327 DOI: 10.2174/1570162x12666140526122709] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 1.7] [Reference Citation Analysis]
123 Bivalkar-Mehla S, Mehla R, Chauhan A. Chimeric peptide-mediated siRNA transduction to inhibit HIV-1 infection. J Drug Target 2017;25:307-19. [PMID: 27800697 DOI: 10.1080/1061186X.2016.1245311] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
124 Nielsen MC, Hvidbjerg Gantzel R, Clària J, Trebicka J, Møller HJ, Grønbæk H. Macrophage Activation Markers, CD163 and CD206, in Acute-on-Chronic Liver Failure. Cells 2020;9:E1175. [PMID: 32397365 DOI: 10.3390/cells9051175] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 9.0] [Reference Citation Analysis]
125 Swan ZD, Bouwer AL, Wonderlich ER, Barratt-Boyes SM. Persistent accumulation of gut macrophages with impaired phagocytic function correlates with SIV disease progression in macaques. Eur J Immunol 2017;47:1925-35. [PMID: 28667761 DOI: 10.1002/eji.201646904] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
126 Lo J, Rosenberg ES, Fitzgerald ML, Bazner SB, Ihenachor EJ, Hawxhurst V, Borkowska AH, Wei J, Zimmerman CO, Burdo TH, Williams KC, Freeman MW, Grinspoon SK. High-density lipoprotein-mediated cholesterol efflux capacity is improved by treatment with antiretroviral therapy in acute human immunodeficiency virus infection. Open Forum Infect Dis 2014;1:ofu108. [PMID: 25734176 DOI: 10.1093/ofid/ofu108] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 2.0] [Reference Citation Analysis]
127 Micci L, Alvarez X, Iriele RI, Ortiz AM, Ryan ES, McGary CS, Deleage C, McAtee BB, He T, Apetrei C, Easley K, Pahwa S, Collman RG, Derdeyn CA, Davenport MP, Estes JD, Silvestri G, Lackner AA, Paiardini M. CD4 depletion in SIV-infected macaques results in macrophage and microglia infection with rapid turnover of infected cells. PLoS Pathog 2014;10:e1004467. [PMID: 25356757 DOI: 10.1371/journal.ppat.1004467] [Cited by in Crossref: 78] [Cited by in F6Publishing: 77] [Article Influence: 9.8] [Reference Citation Analysis]
128 Mullis C, Swartz TH. NLRP3 Inflammasome Signaling as a Link Between HIV-1 Infection and Atherosclerotic Cardiovascular Disease. Front Cardiovasc Med 2020;7:95. [PMID: 32596261 DOI: 10.3389/fcvm.2020.00095] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
129 Vance DE. Prevention, Rehabilitation, and Mitigation Strategies of Cognitive Deficits in Aging with HIV: Implications for Practice and Research. ISRN Nurs 2013;2013:297173. [PMID: 23431469 DOI: 10.1155/2013/297173] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
130 Hsu DC, Ma YF, Hur S, Li D, Rupert A, Scherzer R, Kalapus SC, Deeks S, Sereti I, Hsue PY. Plasma IL-6 levels are independently associated with atherosclerosis and mortality in HIV-infected individuals on suppressive antiretroviral therapy. AIDS 2016;30:2065-74. [PMID: 27177313 DOI: 10.1097/QAD.0000000000001149] [Cited by in Crossref: 56] [Cited by in F6Publishing: 37] [Article Influence: 11.2] [Reference Citation Analysis]
131 Walker JA, Sulciner ML, Nowicki KD, Miller AD, Burdo TH, Williams KC. Elevated numbers of CD163+ macrophages in hearts of simian immunodeficiency virus-infected monkeys correlate with cardiac pathology and fibrosis. AIDS Res Hum Retroviruses 2014;30:685-94. [PMID: 24524407 DOI: 10.1089/AID.2013.0268] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 3.3] [Reference Citation Analysis]
132 Ensoli B, Nchabeleng M, Ensoli F, Tripiciano A, Bellino S, Picconi O, Sgadari C, Longo O, Tavoschi L, Joffe D, Cafaro A, Francavilla V, Moretti S, Pavone Cossut MR, Collacchi B, Arancio A, Paniccia G, Casabianca A, Magnani M, Buttò S, Levendal E, Ndimande JV, Asia B, Pillay Y, Garaci E, Monini P; SMU-MeCRU study group. HIV-Tat immunization induces cross-clade neutralizing antibodies and CD4(+) T cell increases in antiretroviral-treated South African volunteers: a randomized phase II clinical trial. Retrovirology 2016;13:34. [PMID: 27277839 DOI: 10.1186/s12977-016-0261-1] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 3.0] [Reference Citation Analysis]
133 Knudsen TB, Ertner G, Petersen J, Møller HJ, Moestrup SK, Eugen-Olsen J, Kronborg G, Benfield T. Plasma Soluble CD163 Level Independently Predicts All-Cause Mortality in HIV-1-Infected Individuals. J Infect Dis 2016;214:1198-204. [PMID: 27354366 DOI: 10.1093/infdis/jiw263] [Cited by in Crossref: 70] [Cited by in F6Publishing: 75] [Article Influence: 11.7] [Reference Citation Analysis]
134 Mitsi E, Kamng'ona R, Rylance J, Solórzano C, Jesus Reiné J, Mwandumba HC, Ferreira DM, Jambo KC. Human alveolar macrophages predominately express combined classical M1 and M2 surface markers in steady state. Respir Res 2018;19:66. [PMID: 29669565 DOI: 10.1186/s12931-018-0777-0] [Cited by in Crossref: 38] [Cited by in F6Publishing: 39] [Article Influence: 9.5] [Reference Citation Analysis]
135 Wang L, Quan Y, Yue Y, Heng X, Che F. Interleukin-37: A crucial cytokine with multiple roles in disease and potentially clinical therapy. Oncol Lett 2018;15:4711-9. [PMID: 29552110 DOI: 10.3892/ol.2018.7982] [Cited by in Crossref: 8] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
136 Ndhlovu LC, Umaki T, Chew GM, Chow DC, Agsalda M, Kallianpur KJ, Paul R, Zhang G, Ho E, Hanks N, Nakamoto B, Shiramizu BT, Shikuma CM. Treatment intensification with maraviroc (CCR5 antagonist) leads to declines in CD16-expressing monocytes in cART-suppressed chronic HIV-infected subjects and is associated with improvements in neurocognitive test performance: implications for HIV-associated neurocognitive disease (HAND). J Neurovirol 2014;20:571-82. [PMID: 25227930 DOI: 10.1007/s13365-014-0279-x] [Cited by in Crossref: 48] [Cited by in F6Publishing: 51] [Article Influence: 6.0] [Reference Citation Analysis]
137 Møller HJ. Soluble CD163. Scandinavian Journal of Clinical and Laboratory Investigation 2011;72:1-13. [DOI: 10.3109/00365513.2011.626868] [Cited by in Crossref: 218] [Cited by in F6Publishing: 212] [Article Influence: 19.8] [Reference Citation Analysis]
138 Mosepele M, Mohammed T, Mupfumi L, Moyo S, Bennett K, Lockman S, Hemphill LC, Triant VA. HIV disease is associated with increased biomarkers of endothelial dysfunction despite viral suppression on long-term antiretroviral therapy in Botswana. Cardiovasc J Afr 2018;29:155-61. [PMID: 29771268 DOI: 10.5830/CVJA-2018-003] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
139 Andersen MN, Hønge BL, Jespersen S, Medina C, da Silva Té D, Laursen A, Wejse C, Erikstrup C, Møller HJ; Bissau HIV Cohort Study Group. Soluble Macrophage Mannose Receptor (sCD206/sMR) as a Biomarker in Human Immunodeficiency Virus Infection. J Infect Dis 2018;218:1291-5. [PMID: 29800140 DOI: 10.1093/infdis/jiy318] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
140 McKibben RA, Margolick JB, Grinspoon S, Li X, Palella FJ, Kingsley LA, Witt MD, George RT, Jacobson LP, Budoff M. Elevated levels of monocyte activation markers are associated with subclinical atherosclerosis in men with and those without HIV infection. J Infect Dis. 2015;211:1219-1228. [PMID: 25362192 DOI: 10.1093/infdis/jiu594] [Cited by in Crossref: 113] [Cited by in F6Publishing: 116] [Article Influence: 14.1] [Reference Citation Analysis]
141 Shive CL, Judge CJ, Clagett B, Kalayjian RC, Osborn M, Sherman KE, Fichtenbaum C, Gandhi RT, Kang M, Popkin DL, Sieg SF, Lederman MM, Rodriguez B, Anthony DD. Pre-vaccine plasma levels of soluble inflammatory indices negatively predict responses to HAV, HBV, and tetanus vaccines in HCV and HIV infection. Vaccine 2018;36:453-60. [PMID: 29254840 DOI: 10.1016/j.vaccine.2017.12.018] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 2.6] [Reference Citation Analysis]
142 Persidsky Y. Insights into end-organ injury in HIV infection: dynamics of monocyte trafficking to the brain in SIV encephalitis. Am J Pathol 2015;185:1548-51. [PMID: 25963553 DOI: 10.1016/j.ajpath.2015.03.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
143 Psomas C, Younas M, Reynes C, Cezar R, Portalès P, Tuaillon E, Guigues A, Merle C, Atoui N, Fernandez C, Le Moing V, Barbuat C, Marin G, Nagot N, Sotto A, Eliaou JF, Sabatier R, Reynes J, Corbeau P. One of the immune activation profiles observed in HIV-1-infected adults with suppressed viremia is linked to metabolic syndrome: The ACTIVIH study. EBioMedicine 2016;8:265-76. [PMID: 27428436 DOI: 10.1016/j.ebiom.2016.05.008] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 3.2] [Reference Citation Analysis]
144 Cheru LT, Saylor CF, Fitch KV, Looby SE, Lu M, Hoffmann U, Stanley TL, Lo J. Low vitamin D is associated with coronary atherosclerosis in women with HIV. Antivir Ther 2019;24:505-12. [PMID: 31742564 DOI: 10.3851/IMP3336] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
145 Neff CP, Atif SM, Logue EC, Siebert J, Görg C, Lavelle J, Fiorillo S, Twigg H, Campbell TB, Fontenot AP, Palmer BE. HIV Infection Is Associated with Loss of Anti-Inflammatory Alveolar Macrophages. J Immunol 2020;205:2447-55. [PMID: 32929038 DOI: 10.4049/jimmunol.2000361] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
146 Judge CJ, Sandberg JK, Funderburg NT, Sherman KE, Butt AA, Kang M, Landay AL, Lederman MM, Anthony DD. Brief Report: CD14brightCD16- monocytes and sCD14 level negatively associate with CD4-memory T-cell frequency and predict HCV-decline on therapy. J Acquir Immune Defic Syndr 2016;73:258-62. [PMID: 27258231 DOI: 10.1097/QAI.0000000000001104] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
147 Monnig MA, Cohen R, Ramratnam B, McAdams M, Tashima K, Monti PM. HIV Infection, HCV Coinfection, and Alcohol Use: Associations with Microbial Translocation and Immune Activation. Alcohol Clin Exp Res 2019;43:1126-34. [PMID: 30908642 DOI: 10.1111/acer.14032] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
148 Kovacs L, Bruder-Nascimento T, Greene L, Kennard S, Belin de Chantemèle EJ. Chronic Exposure to HIV-Derived Protein Tat Impairs Endothelial Function via Indirect Alteration in Fat Mass and Nox1-Mediated Mechanisms in Mice. Int J Mol Sci 2021;22:10977. [PMID: 34681637 DOI: 10.3390/ijms222010977] [Reference Citation Analysis]
149 Dirajlal-Fargo S, Alam K, Sattar A, Kulkarni M, Funderburg N, Wilson WH, McComsey GA. Comprehensive assessment of the arginine pathway and its relationship to inflammation in HIV. AIDS 2017;31:533-7. [PMID: 27922857 DOI: 10.1097/QAD.0000000000001363] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
150 Burdo TH, Lackner A, Williams KC. Monocyte/macrophages and their role in HIV neuropathogenesis. Immunol Rev 2013;254:102-13. [PMID: 23772617 DOI: 10.1111/imr.12068] [Cited by in Crossref: 128] [Cited by in F6Publishing: 121] [Article Influence: 16.0] [Reference Citation Analysis]
151 Canton J, Neculai D, Grinstein S. Scavenger receptors in homeostasis and immunity. Nat Rev Immunol. 2013;13:621-634. [PMID: 23928573 DOI: 10.1038/nri3515] [Cited by in Crossref: 432] [Cited by in F6Publishing: 406] [Article Influence: 48.0] [Reference Citation Analysis]
152 Kroeze S, Rossouw TM, Steel HC, Wit FW, Kityo CM, Siwale M, Akanmu S, Mandaliya K, De Jager M, Ondoa P, Reiss P, De Wit TFR, Kootstra NA, Hamers RL. Plasma inflammatory biomarkers predict CD4+ T-cell recovery and viral rebound in HIV-1 infected Africans on suppressive antiretroviral therapy. J Infect Dis 2020:jiaa787. [PMID: 33373447 DOI: 10.1093/infdis/jiaa787] [Reference Citation Analysis]
153 Espíndola MS, Soares LS, Galvão-lima LJ, Zambuzi FA, Cacemiro MC, Brauer VS, Frantz FG. HIV infection: focus on the innate immune cells. Immunol Res 2016;64:1118-32. [DOI: 10.1007/s12026-016-8862-2] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 2.8] [Reference Citation Analysis]
154 Chaudhary O, Narayan V, Lelis F, Linz B, Watkins M, Veazey R, Aldovini A. Inhibition of p38 MAPK in combination with ART reduces SIV-induced immune activation and provides additional protection from immune system deterioration. PLoS Pathog 2018;14:e1007268. [PMID: 30161247 DOI: 10.1371/journal.ppat.1007268] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
155 Mosepele M, Hemphill LC, Moloi W, Moyo S, Nkele I, Makhema J, Bennett K, Triant VA, Lockman S. Pre-clinical carotid atherosclerosis and sCD163 among virally suppressed HIV patients in Botswana compared with uninfected controls. PLoS One 2017;12:e0179994. [PMID: 28662159 DOI: 10.1371/journal.pone.0179994] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
156 Veenstra M, Byrd DA, Inglese M, Buyukturkoglu K, Williams DW, Fleysher L, Li M, Gama L, León-Rivera R, Calderon TM, Clements JE, Morgello S, Berman JW. CCR2 on Peripheral Blood CD14+CD16+ Monocytes Correlates with Neuronal Damage, HIV-Associated Neurocognitive Disorders, and Peripheral HIV DNA: reseeding of CNS reservoirs? J Neuroimmune Pharmacol 2019;14:120-33. [PMID: 29981000 DOI: 10.1007/s11481-018-9792-7] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 4.0] [Reference Citation Analysis]
157 Patro SC, Azzoni L, Joseph J, Fair MG, Sierra-Madero JG, Rassool MS, Sanne I, Montaner LJ. Antiretroviral therapy in HIV-1-infected individuals with CD4 count below 100 cells/mm3 results in differential recovery of monocyte activation. J Leukoc Biol 2016;100:223-31. [PMID: 26609048 DOI: 10.1189/jlb.5AB0915-406R] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
158 Rosenberg NE, Pilcher CD, Busch MP, Cohen MS. How can we better identify early HIV infections? Curr Opin HIV AIDS 2015;10:61-8. [PMID: 25389806 DOI: 10.1097/COH.0000000000000121] [Cited by in Crossref: 43] [Cited by in F6Publishing: 30] [Article Influence: 6.1] [Reference Citation Analysis]
159 Carreras-badosa G, Prats-puig A, Diaz-roldan F, Platero-gutierrez E, Osiniri I, Riera-perez E, de Zegher F, Ibañez L, Bassols J, López-bermejo A. The macrophage activation product sCD163 is associated with a less favourable metabolic profile in prepubertal children: Soluble CD163 and metabolic profile. Pediatric Obesity 2016;11:543-50. [DOI: 10.1111/ijpo.12104] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
160 Boerwinkle AH, Strain JF, Burdo T, Doyle J, Christensen J, Su Y, Wisch JK, Cooley SA, Vaida F, Smith MD, Jafri H, Paul RH, Benzinger TLS, Ances BM. Comparison of [11C]-PBR28 Binding Between Persons Living With HIV and HIV-Uninfected Individuals. J Acquir Immune Defic Syndr 2020;85:244-51. [PMID: 32658129 DOI: 10.1097/QAI.0000000000002435] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
161 Tuluc F, Meshki J, Spitsin S, Douglas SD. HIV infection of macrophages is enhanced in the presence of increased expression of CD163 induced by substance P. J Leukoc Biol 2014;96:143-50. [PMID: 24577568 DOI: 10.1189/jlb.4AB0813-434RR] [Cited by in Crossref: 21] [Cited by in F6Publishing: 15] [Article Influence: 2.6] [Reference Citation Analysis]
162 Iannetta M, Savinelli S, Rossi R, Mascia C, Marocco R, Vita S, Zuccalà P, Zingaropoli MA, Mengoni F, Massetti AP, Falciano M, d'Ettorre G, Ciardi MR, Mastroianni CM, Vullo V, Lichtner M. Myeloid and lymphoid activation markers in AIDS and non-AIDS presenters. Immunobiology 2019;224:231-41. [PMID: 30522891 DOI: 10.1016/j.imbio.2018.11.011] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
163 Scriven JE, Rhein J, Hullsiek KH, von Hohenberg M, Linder G, Rolfes MA, Williams DA, Taseera K, Meya DB, Meintjes G, Boulware DR; COAT Team. Early ART After Cryptococcal Meningitis Is Associated With Cerebrospinal Fluid Pleocytosis and Macrophage Activation in a Multisite Randomized Trial. J Infect Dis 2015;212:769-78. [PMID: 25651842 DOI: 10.1093/infdis/jiv067] [Cited by in Crossref: 41] [Cited by in F6Publishing: 39] [Article Influence: 5.9] [Reference Citation Analysis]
164 Carroll A, Brew B. HIV-associated neurocognitive disorders: recent advances in pathogenesis, biomarkers, and treatment. F1000Res 2017;6:312. [PMID: 28413625 DOI: 10.12688/f1000research.10651.1] [Cited by in Crossref: 57] [Cited by in F6Publishing: 52] [Article Influence: 11.4] [Reference Citation Analysis]
165 Saylor D, Dickens AM, Sacktor N, Haughey N, Slusher B, Pletnikov M, Mankowski JL, Brown A, Volsky DJ, McArthur JC. HIV-associated neurocognitive disorder--pathogenesis and prospects for treatment. Nat Rev Neurol 2016;12:234-48. [PMID: 26965674 DOI: 10.1038/nrneurol.2016.27] [Cited by in Crossref: 362] [Cited by in F6Publishing: 349] [Article Influence: 60.3] [Reference Citation Analysis]
166 Chen S, Wang X, Zhu H, Tang Q, Du W, Cao H, Lai C, Guo W, Fu L, Lu W. Zidovudine-Based Treatments Inhibit the Glycosylation of ADAM17 and Reduce CD163 Shedding From Monocytes. J Acquir Immune Defic Syndr 2018;79:126-34. [PMID: 29794822 DOI: 10.1097/QAI.0000000000001769] [Reference Citation Analysis]
167 Beltrán LM, Rubio-Navarro A, Amaro-Villalobos JM, Egido J, García-Puig J, Moreno JA. Influence of immune activation and inflammatory response on cardiovascular risk associated with the human immunodeficiency virus. Vasc Health Risk Manag 2015;11:35-48. [PMID: 25609975 DOI: 10.2147/VHRM.S65885] [Cited by in Crossref: 8] [Cited by in F6Publishing: 15] [Article Influence: 1.1] [Reference Citation Analysis]
168 Nielsen MC, Andersen MN, Grønbæk H, Damgaard Sandahl T, Møller HJ. Extracellular vesicle-associated soluble CD163 and CD206 in patients with acute and chronic inflammatory liver disease. Scandinavian Journal of Gastroenterology 2020;55:588-96. [DOI: 10.1080/00365521.2020.1759140] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
169 Strain JF, Burdo TH, Song SK, Sun P, El-Ghazzawy O, Nelson B, Westerhaus E, Baker L, Vaida F, Ances BM. Diffusion Basis Spectral Imaging Detects Ongoing Brain Inflammation in Virologically Well-Controlled HIV+ Patients. J Acquir Immune Defic Syndr 2017;76:423-30. [PMID: 28796748 DOI: 10.1097/QAI.0000000000001513] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 2.8] [Reference Citation Analysis]
170 Tang Y, Ma C, Sun H, Yang S, Yu F, Li X, Wang L. Serum Levels of Seven General Cytokines in Acute Brucellosis Before and After Treatment. Infect Drug Resist 2021;14:5501-10. [PMID: 34955644 DOI: 10.2147/IDR.S341331] [Reference Citation Analysis]
171 Hunt PW, Sinclair E, Rodriguez B, Shive C, Clagett B, Funderburg N, Robinson J, Huang Y, Epling L, Martin JN. Gut epithelial barrier dysfunction and innate immune activation predict mortality in treated HIV infection. J Infect Dis. 2014;210:1228-1238. [PMID: 24755434 DOI: 10.1093/infdis/jiu238] [Cited by in Crossref: 287] [Cited by in F6Publishing: 295] [Article Influence: 35.9] [Reference Citation Analysis]
172 Jain V, Hartogensis W, Bacchetti P, Hunt PW, Hatano H, Sinclair E, Epling L, Lee TH, Busch MP, McCune JM, Pilcher CD, Hecht FM, Deeks SG. Antiretroviral therapy initiated within 6 months of HIV infection is associated with lower T-cell activation and smaller HIV reservoir size. J Infect Dis 2013;208:1202-11. [PMID: 23852127 DOI: 10.1093/infdis/jit311] [Cited by in Crossref: 215] [Cited by in F6Publishing: 205] [Article Influence: 23.9] [Reference Citation Analysis]
173 Ploquin MJ, Madec Y, Casrouge A, Huot N, Passaes C, Lécuroux C, Essat A, Boufassa F, Jacquelin B, Jochems SP, Petitjean G, Angin M, Gärtner K, Garcia-Tellez T, Noël N, Booiman T, Boeser-Nunnink BD, Roques P, Saez-Cirion A, Vaslin B, Dereudre-Bosquet N, Barré-Sinoussi F, Ghislain M, Rouzioux C, Lambotte O, Albert ML, Goujard C, Kootstra N, Meyer L, Müller-Trutwin MC. Elevated Basal Pre-infection CXCL10 in Plasma and in the Small Intestine after Infection Are Associated with More Rapid HIV/SIV Disease Onset. PLoS Pathog 2016;12:e1005774. [PMID: 27509048 DOI: 10.1371/journal.ppat.1005774] [Cited by in Crossref: 36] [Cited by in F6Publishing: 33] [Article Influence: 6.0] [Reference Citation Analysis]
174 Pirrone V, Libon DJ, Sell C, Lerner CA, Nonnemacher MR, Wigdahl B. Impact of age on markers of HIV-1 disease. Future Virol 2013;8:81-101. [PMID: 23596462 DOI: 10.2217/fvl.12.127] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
175 Beck SE, Queen SE, Witwer KW, Metcalf Pate KA, Mangus LM, Gama L, Adams RJ, Clements JE, Christine Zink M, Mankowski JL. Paving the path to HIV neurotherapy: Predicting SIV CNS disease. Eur J Pharmacol 2015;759:303-12. [PMID: 25818747 DOI: 10.1016/j.ejphar.2015.03.018] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 3.1] [Reference Citation Analysis]
176 Spitsin S, Stevens KE, Douglas SD. Expression of substance P, neurokinin-1 receptor and immune markers in the brains of individuals with HIV-associated neuropathology. J Neurol Sci 2013;334:18-23. [PMID: 23916293 DOI: 10.1016/j.jns.2013.07.008] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
177 Ryan ES, Micci L, Fromentin R, Paganini S, McGary CS, Easley K, Chomont N, Paiardini M. Loss of Function of Intestinal IL-17 and IL-22 Producing Cells Contributes to Inflammation and Viral Persistence in SIV-Infected Rhesus Macaques. PLoS Pathog 2016;12:e1005412. [PMID: 26829644 DOI: 10.1371/journal.ppat.1005412] [Cited by in Crossref: 42] [Cited by in F6Publishing: 44] [Article Influence: 7.0] [Reference Citation Analysis]
178 Olwenyi OA, Naluyima P, Cham F, Quinn TC, Serwadda D, Sewankambo NK, Gray RH, Sandberg JK, Michael NL, Wabwire-Mangen F, Robb ML, Eller MA. Brief Report: Differential Associations of Interleukin 6 and Intestinal Fatty Acid-Binding Protein With Progressive Untreated HIV-1 Infection in Rakai, Uganda. J Acquir Immune Defic Syndr 2016;72:15-20. [PMID: 26630672 DOI: 10.1097/QAI.0000000000000915] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
179 Hearps AC, Maisa A, Cheng WJ, Angelovich TA, Lichtfuss GF, Palmer CS, Landay AL, Jaworowski A, Crowe SM. HIV infection induces age-related changes to monocytes and innate immune activation in young men that persist despite combination antiretroviral therapy. AIDS. 2012;26:843-853. [PMID: 22313961 DOI: 10.1097/qad.0b013e328351f756] [Cited by in Crossref: 108] [Cited by in F6Publishing: 76] [Article Influence: 10.8] [Reference Citation Analysis]
180 Cao B, Kong X, Kettering C, Yu P, Ragin A. Determinants of HIV-induced brain changes in three different periods of the early clinical course: A data mining analysis. Neuroimage Clin 2015;9:75-82. [PMID: 26413474 DOI: 10.1016/j.nicl.2015.07.012] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
181 Cai CW, Sereti I. Residual immune dysfunction under antiretroviral therapy. Semin Immunol 2021;:101471. [PMID: 33674177 DOI: 10.1016/j.smim.2021.101471] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
182 Nowlin BT, Burdo TH, Midkiff CC, Salemi M, Alvarez X, Williams KC. SIV encephalitis lesions are composed of CD163(+) macrophages present in the central nervous system during early SIV infection and SIV-positive macrophages recruited terminally with AIDS. Am J Pathol 2015;185:1649-65. [PMID: 25963554 DOI: 10.1016/j.ajpath.2015.01.033] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 4.0] [Reference Citation Analysis]
183 Stein JH, Currier JS, Hsue PY. Arterial disease in patients with human immunodeficiency virus infection: what has imaging taught us? JACC Cardiovasc Imaging 2014;7:515-25. [PMID: 24831212 DOI: 10.1016/j.jcmg.2013.08.019] [Cited by in Crossref: 34] [Cited by in F6Publishing: 35] [Article Influence: 4.9] [Reference Citation Analysis]
184 Tebas P, Spitsin S, Barrett JS, Tuluc F, Elci O, Korelitz JJ, Wagner W, Winters A, Kim D, Catalano R, Evans DL, Douglas SD. Reduction of soluble CD163, substance P, programmed death 1 and inflammatory markers: phase 1B trial of aprepitant in HIV-1-infected adults. AIDS 2015;29:931-9. [PMID: 25915168 DOI: 10.1097/QAD.0000000000000638] [Cited by in Crossref: 20] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
185 Rudy BJ, Kapogiannis BG, Worrell C, Squires K, Bethel J, Li S, Wilson CM, Agwu A, Emmanuel P, Price G, Hudey S, Goodenow MM, Sleasman JW; Adolescent Trials Network for HIVAIDS Interventions. Immune Reconstitution but Persistent Activation After 48 Weeks of Antiretroviral Therapy in Youth With Pre-Therapy CD4 >350 in ATN 061. J Acquir Immune Defic Syndr 2015;69:52-60. [PMID: 25942459 DOI: 10.1097/QAI.0000000000000549] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 2.4] [Reference Citation Analysis]
186 Pallikkuth S, Bolivar H, Fletcher MA, Babic DZ, De Armas LR, Gupta S, Termini JM, Arheart KL, Stevenson M, Tung FY, Fischl MA, Pahwa S, Stone GW. A therapeutic HIV-1 vaccine reduces markers of systemic immune activation and latent infection in patients under highly active antiretroviral therapy. Vaccine 2020;38:4336-45. [PMID: 32387010 DOI: 10.1016/j.vaccine.2020.04.015] [Reference Citation Analysis]
187 Sunil M, Nigalye M, Somasunderam A, Martinez ML, Yu X, Arduino RC, Utay NS, Bell TK. Unchanged Levels of Soluble CD14 and IL-6 Over Time Predict Serious Non-AIDS Events in HIV-1-Infected People. AIDS Res Hum Retroviruses 2016;32:1205-9. [PMID: 27344921 DOI: 10.1089/AID.2016.0007] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
188 Sandler NG, Douek DC. Microbial translocation in HIV infection: causes, consequences and treatment opportunities. Nat Rev Microbiol. 2012;10:655-666. [PMID: 22886237 DOI: 10.1038/nrmicro2848] [Cited by in Crossref: 268] [Cited by in F6Publishing: 257] [Article Influence: 26.8] [Reference Citation Analysis]
189 Cacemiro MC, Espíndola MS, Galvão-Lima LJ, Soares LS, Fontanari C, Prata MA, Campioni F, Falcão JP, Bollela VR, Frantz FG. Immune Response Against Salmonella Enteritidis Is Unsettled by HIV Infection. Adv Exp Med Biol 2018;1057:29-39. [PMID: 28447329 DOI: 10.1007/5584_2017_40] [Reference Citation Analysis]
190 Azzoni L, Metzger D, Montaner LJ. Effect of Opioid Use on Immune Activation and HIV Persistence on ART. J Neuroimmune Pharmacol 2020;15:643-57. [PMID: 32974750 DOI: 10.1007/s11481-020-09959-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
191 Lee SA, Sinclair E, Jain V, Huang Y, Epling L, Van Natta M, Meinert CL, Martin JN, McCune JM, Deeks SG, Lederman MM, Hecht FM, Hunt PW. Low proportions of CD28- CD8+ T cells expressing CD57 can be reversed by early ART initiation and predict mortality in treated HIV infection. J Infect Dis 2014;210:374-82. [PMID: 24585893 DOI: 10.1093/infdis/jiu109] [Cited by in Crossref: 42] [Cited by in F6Publishing: 47] [Article Influence: 5.3] [Reference Citation Analysis]
192 Williams JC, Zhang X, Karki M, Chi YY, Wallet SM, Rudy BJ, Nichols SL, Goodenow MM, Sleasman JW. Soluble CD14, CD163, and CD27 biomarkers distinguish ART-suppressed youth living with HIV from healthy controls. J Leukoc Biol 2018;103:671-80. [PMID: 29377283 DOI: 10.1002/JLB.3A0717-294RR] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 2.8] [Reference Citation Analysis]
193 Kearns AC, Liu F, Dai S, Robinson JA, Kiernan E, Tesfaye Cheru L, Peng X, Gordon J, Morgello S, Abuova A, Lo J, Zanni MV, Grinspoon SK, Burdo TH, Qin 秦学斌 X. Caspase-1 Activation Is Related With HIV-Associated Atherosclerosis in an HIV Transgenic Mouse Model and HIV Patient Cohort. Arterioscler Thromb Vasc Biol 2019;39:1762-75. [PMID: 31315440 DOI: 10.1161/ATVBAHA.119.312603] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
194 Eberhard JM, Hartjen P, Kummer S, Schmidt RE, Bockhorn M, Lehmann C, Balagopal A, Hauber J, van Lunzen J, Schulze zur Wiesch J. CD161+ MAIT cells are severely reduced in peripheral blood and lymph nodes of HIV-infected individuals independently of disease progression. PLoS One. 2014;9:e111323. [PMID: 25369333 DOI: 10.1371/journal.pone.0111323] [Cited by in Crossref: 44] [Cited by in F6Publishing: 41] [Article Influence: 5.5] [Reference Citation Analysis]
195 Peluso MJ, Hellmuth J, Chow FC. Central Nervous System Effects of COVID-19 in People with HIV Infection. Curr HIV/AIDS Rep 2021;18:538-48. [PMID: 34843065 DOI: 10.1007/s11904-021-00582-x] [Reference Citation Analysis]
196 Dye CK, Corley MJ, Li D, Khadka VS, Mitchell BI, Sultana R, Lum-Jones A, Shikuma CM, Ndhlovu LC, Maunakea AK. Comparative DNA methylomic analyses reveal potential origins of novel epigenetic biomarkers of insulin resistance in monocytes from virally suppressed HIV-infected adults. Clin Epigenetics 2019;11:95. [PMID: 31253200 DOI: 10.1186/s13148-019-0694-1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
197 Utay NS, Monczor AN, Somasunderam A, Lupo S, Jiang ZD, Alexander AS, Finkelman M, Vigil KJ, Lake JE, Hanson B, DuPont HL, Arduino RC. Evaluation of Six Weekly Oral Fecal Microbiota Transplants in People with HIV. Pathog Immun 2020;5:364-81. [PMID: 33501400 DOI: 10.20411/pai.v5i1.388] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
198 North CM, Muyanja D, Kakuhikire B, Tsai AC, Tracy RP, Hunt PW, Kwon DS, Christiani DC, Okello S, Siedner MJ. Brief Report: Systemic Inflammation, Immune Activation, and Impaired Lung Function Among People Living With HIV in Rural Uganda. J Acquir Immune Defic Syndr 2018;78:543-8. [PMID: 29683991 DOI: 10.1097/QAI.0000000000001711] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 3.3] [Reference Citation Analysis]
199 Zicari S, Sessa L, Cotugno N, Ruggiero A, Morrocchi E, Concato C, Rocca S, Zangari P, Manno EC, Palma P. Immune Activation, Inflammation, and Non-AIDS Co-Morbidities in HIV-Infected Patients under Long-Term ART. Viruses 2019;11:E200. [PMID: 30818749 DOI: 10.3390/v11030200] [Cited by in Crossref: 86] [Cited by in F6Publishing: 80] [Article Influence: 28.7] [Reference Citation Analysis]
200 Soares LS, Espíndola MS, Zambuzi FA, Galvão-Lima LJ, Cacemiro MC, Soares MR, Santana BA, Calado RT, Bollela VR, Frantz FG. Immunosenescence in chronic HIV infected patients impairs essential functions of their natural killer cells. Int Immunopharmacol 2020;84:106568. [PMID: 32408187 DOI: 10.1016/j.intimp.2020.106568] [Reference Citation Analysis]
201 Schnittman SR, Deitchman AN, Beck-Engeser G, Ahn H, York VA, Hartig H, Hecht FM, Martin JN, Deeks SG, Aweeka FT, Hunt PW. Abnormal Levels of Some Biomarkers of Immune Activation Despite Very Early Treatment of Human Immunodeficiency Virus. J Infect Dis 2021;223:1621-30. [PMID: 32915986 DOI: 10.1093/infdis/jiaa580] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
202 Paul R, Garcia-Egan P, Bolzenius J, Mannarino J. Deep Phenotyping of HIV Neurocognitive Complications Among Individuals Residing in High-Income Countries. Curr Top Behav Neurosci 2021;50:245-69. [PMID: 33442841 DOI: 10.1007/7854_2020_185] [Reference Citation Analysis]
203 Sessa L, Reddel S, Manno E, Quagliariello A, Cotugno N, Del Chierico F, Amodio D, Capponi C, Leone F, Bernardi S, Rossi P, Putignani L, Palma P. Distinct gut microbiota profile in antiretroviral therapy-treated perinatally HIV-infected patients associated with cardiac and inflammatory biomarkers. AIDS 2019;33:1001-11. [PMID: 30946154 DOI: 10.1097/QAD.0000000000002131] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 8.5] [Reference Citation Analysis]
204 Mendonça VR, Luz NF, Santos NJ, Borges VM, Gonçalves MS, Andrade BB, Barral-Netto M. Association between the haptoglobin and heme oxygenase 1 genetic profiles and soluble CD163 in susceptibility to and severity of human malaria. Infect Immun 2012;80:1445-54. [PMID: 22290142 DOI: 10.1128/IAI.05933-11] [Cited by in Crossref: 50] [Cited by in F6Publishing: 39] [Article Influence: 5.0] [Reference Citation Analysis]
205 Pastor L, Parker E, Carrillo J, Urrea V, Fuente-Soro L, Respeito D, Jairoce C, Mandomando I, Blanco J, Naniche D. A Cytokine Pattern That Differentiates Preseroconversion From Postseroconversion Phases of Primary HIV Infection. J Acquir Immune Defic Syndr 2017;74:459-66. [PMID: 28225519 DOI: 10.1097/QAI.0000000000001272] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
206 Højen JF, Rasmussen TA, Andersen KL, Winckelmann AA, Laursen RR, Gunst JD, Møller HJ, Fujita M, Østergaard L, Søgaard OS, Dinarello CA, Tolstrup M. Interleukin-37 Expression Is Increased in Chronic HIV-1-Infected Individuals and Is Associated with Inflammation and the Size of the Total Viral Reservoir. Mol Med 2015;21:337-45. [PMID: 25879630 DOI: 10.2119/molmed.2015.00031] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 4.0] [Reference Citation Analysis]
207 Burdo TH, Lo J, Abbara S, Wei J, DeLelys ME, Preffer F, Rosenberg ES, Williams KC, Grinspoon S. Soluble CD163, a novel marker of activated macrophages, is elevated and associated with noncalcified coronary plaque in HIV-infected patients. J Infect Dis. 2011;204:1227-1236. [PMID: 21917896 DOI: 10.1093/infdis/jir520] [Cited by in Crossref: 293] [Cited by in F6Publishing: 298] [Article Influence: 26.6] [Reference Citation Analysis]
208 Yadav A, Kossenkov AV, Knecht VR, Showe LC, Ratcliffe SJ, Montaner LJ, Tebas P, Collman RG. Evidence for Persistent Monocyte and Immune Dysregulation After Prolonged Viral Suppression Despite Normalization of Monocyte Subsets, sCD14 and sCD163 in HIV-Infected Individuals. Pathog Immun 2019;4:324-62. [PMID: 31893252 DOI: 10.20411/pai.v4i2.336] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
209 Lakritz JR, Bodair A, Shah N, O'Donnell R, Polydefkis MJ, Miller AD, Burdo TH. Monocyte Traffic, Dorsal Root Ganglion Histopathology, and Loss of Intraepidermal Nerve Fiber Density in SIV Peripheral Neuropathy. Am J Pathol 2015;185:1912-23. [PMID: 25956030 DOI: 10.1016/j.ajpath.2015.03.007] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 3.1] [Reference Citation Analysis]
210 Xing Y, Shepherd N, Lan J, Li W, Rane S, Gupta SK, Zhang S, Dong J, Yu Q. MMPs/TIMPs imbalances in the peripheral blood and cerebrospinal fluid are associated with the pathogenesis of HIV-1-associated neurocognitive disorders. Brain Behav Immun 2017;65:161-72. [PMID: 28487203 DOI: 10.1016/j.bbi.2017.04.024] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 6.2] [Reference Citation Analysis]
211 Kim-Chang JJ, Wilson L, Chan C, Fischer B, Venturi G, Goodenow MM, Aldrovandi G, Weber TJ, Sleasman JW; Adolescent Medicine Trials Network for HIV/AIDS Interventions. Tenofovir Has Minimal Effect on Biomarkers of Bone Health in Youth with HIV Receiving Initial Antiretroviral Therapy. AIDS Res Hum Retroviruses 2019;35:746-54. [PMID: 31115244 DOI: 10.1089/AID.2018.0270] [Reference Citation Analysis]
212 Fourman LT, Czerwonka N, Shaikh SD, Stanley TL, Burdo TH, Williams KC, Fitch KV, Lo J, Grinspoon SK. Insulin-like growth factor 1 inversely relates to monocyte/macrophage activation markers in HIV. AIDS 2018;32:927-32. [PMID: 29424780 DOI: 10.1097/QAD.0000000000001775] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
213 Wilson EM, Singh A, Hullsiek KH, Gibson D, Henry WK, Lichtenstein K, Önen NF, Kojic E, Patel P, Brooks JT, Sereti I, Baker JV; Study to Understand the Natural History of HIV/AIDS in the Era of Effective Therapy (SUN Study) Investigators. Monocyte-activation phenotypes are associated with biomarkers of inflammation and coagulation in chronic HIV infection. J Infect Dis 2014;210:1396-406. [PMID: 24813472 DOI: 10.1093/infdis/jiu275] [Cited by in Crossref: 60] [Cited by in F6Publishing: 60] [Article Influence: 7.5] [Reference Citation Analysis]
214 Alcaide ML, Parmigiani A, Pallikkuth S, Roach M, Freguja R, Della Negra M, Bolivar H, Fischl MA, Pahwa S. Immune activation in HIV-infected aging women on antiretrovirals--implications for age-associated comorbidities: a cross-sectional pilot study. PLoS One 2013;8:e63804. [PMID: 23724003 DOI: 10.1371/journal.pone.0063804] [Cited by in Crossref: 54] [Cited by in F6Publishing: 52] [Article Influence: 6.0] [Reference Citation Analysis]
215 Delery EC, MacLean AG. Chronic Viral Neuroinflammation: Speculation on Underlying Mechanisms. Viral Immunol 2019;32:55-62. [PMID: 30260764 DOI: 10.1089/vim.2018.0093] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
216 Swaminathan S, Hu Z, Rupert AW, Higgins JM, Dewar RL, Stevens R, Chen Q, Rehm CA, Metcalf JA, Baseler MW, Lane HC, Imamichi T. Plasma interleukin-27 (IL-27) levels are not modulated in patients with chronic HIV-1 infection. PLoS One 2014;9:e98989. [PMID: 24896094 DOI: 10.1371/journal.pone.0098989] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
217 Murray KD, Singh MV, Zhuang Y, Uddin MN, Qiu X, Weber MT, Tivarus ME, Wang HZ, Sahin B, Zhong J, Maggirwar SB, Schifitto G. Pathomechanisms of HIV-Associated Cerebral Small Vessel Disease: A Comprehensive Clinical and Neuroimaging Protocol and Analysis Pipeline. Front Neurol 2020;11:595463. [PMID: 33384655 DOI: 10.3389/fneur.2020.595463] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
218 Wang J, Guo W, Du H, Yu H, Jiang W, Zhu T, Bai X, Wang P. Elevated soluble CD163 plasma levels are associated with disease severity in patients with hemorrhagic fever with renal syndrome. PLoS One 2014;9:e112127. [PMID: 25392926 DOI: 10.1371/journal.pone.0112127] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
219 Schrier RD, Hong S, Crescini M, Ellis R, Pérez-Santiago J, Spina C, Letendre S; HNRP Group. Cerebrospinal fluid (CSF) CD8+ T-cells that express interferon-gamma contribute to HIV associated neurocognitive disorders (HAND). PLoS One 2015;10:e0116526. [PMID: 25719800 DOI: 10.1371/journal.pone.0116526] [Cited by in Crossref: 45] [Cited by in F6Publishing: 44] [Article Influence: 6.4] [Reference Citation Analysis]
220 Barton JH, Ireland A, Fitzpatrick M, Kessinger C, Camp D, Weinman R, McMahon D, Leader JK, Holguin F, Wenzel SE, Morris A, Gingo MR. Adiposity influences airway wall thickness and the asthma phenotype of HIV-associated obstructive lung disease: a cross-sectional study. BMC Pulm Med 2016;16:111. [PMID: 27488495 DOI: 10.1186/s12890-016-0274-5] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
221 Hatano H. Immune activation and HIV persistence: considerations for novel therapeutic interventions. Curr Opin HIV AIDS. 2013;8:211-216. [PMID: 23454864 DOI: 10.1097/coh.0b013e32835f9788] [Cited by in Crossref: 54] [Cited by in F6Publishing: 37] [Article Influence: 6.0] [Reference Citation Analysis]
222 Longenecker CT, Triant VA. Initiation of antiretroviral therapy at high CD4 cell counts: does it reduce the risk of cardiovascular disease? Curr Opin HIV AIDS 2014;9:54-62. [PMID: 24275676 DOI: 10.1097/COH.0000000000000015] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 2.9] [Reference Citation Analysis]
223 Soulas C, Autissier PJ, Burdo TH, Piatak M Jr, Lifson JD, Williams KC. Distinct phenotype, longitudinal changes of numbers and cell-associated virus in blood dendritic cells in SIV-infected CD8-lymphocyte depleted macaques. PLoS One 2015;10:e0119764. [PMID: 25915601 DOI: 10.1371/journal.pone.0119764] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
224 Siwamogsatham S, Chutinet A, Vongsayan P, Samajarn J, Putcharoen O, Aponpong T, Hiransuthikul A, Gatechompol S, Han WM, Chattranukulchai P, Kerr SJ, Ruxrungtham K, Avihingsanon A; HIV-NAT 227/HIV-NAT006 study team. Low CD4 Cell Counts Are Associated with Carotid Plaque and Intima-Media Thickness in Virologically Suppressed HIV-Infected Asians Older Than 50 Years. AIDS Res Hum Retroviruses 2019;35:1160-9. [PMID: 31530175 DOI: 10.1089/AID.2019.0126] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
225 Srinivasa S, Fitch KV, Petrow E, Burdo TH, Williams KC, Lo J, Cȏté HCF, Grinspoon SK. Soluble CD163 is associated with shortened telomere length in HIV-infected patients. J Acquir Immune Defic Syndr 2014;67:414-8. [PMID: 25197827 DOI: 10.1097/QAI.0000000000000329] [Cited by in Crossref: 19] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
226 Guo L, Niu J, Yu H, Gu W, Li R, Luo X, Huang M, Tian Z, Feng L, Wang Y. Modulation of CD163 expression by metalloprotease ADAM17 regulates porcine reproductive and respiratory syndrome virus entry. J Virol 2014;88:10448-58. [PMID: 24965453 DOI: 10.1128/JVI.01117-14] [Cited by in Crossref: 33] [Cited by in F6Publishing: 24] [Article Influence: 4.1] [Reference Citation Analysis]
227 Utay NS, Hunt PW. Role of immune activation in progression to AIDS. Curr Opin HIV AIDS 2016;11:131-7. [PMID: 26731430 DOI: 10.1097/COH.0000000000000242] [Cited by in Crossref: 28] [Cited by in F6Publishing: 23] [Article Influence: 4.7] [Reference Citation Analysis]